PROFESSIONAL POST

Associate Professor, Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan

Education

1) Ph.D., University of Sheffield, United Kingdom (2007)

2) M.D., Taipei Medical University, Taiwan (1993)

RESEARCH INTEREST

1)     Molecular Genetics and Pathogenesis of Polycystic Kidney Disease

2)     Zebrafish models of human diseases

3)     Critical Care Nephrology

AWARD

1)     Annual Research Award, Taiwan Society of Nephrology, 2012

2)     Best Paper Award, Annual Meeting of Taiwan Society of Nephrology, 2010

3)     Annual Research Award, Taiwan Society of Nephrology, 2008

Professional ACTIVITIES

1)     Taiwan Society of Nephrology

2)     Taiwan Society of Internal Medicine

3)     The Society of Ultrasound in Medicine, R.O.C.

4)     Renal Association, United Kingdom

5)     American Society of Nephrology, USA

MAJOR BIBLIOGRAPHY (limited 10 papers)

1)      Chen IJ, Chang MY, Chiao SL, Chen JL, Yu CC, Yang SH, Liu JM, Hung CC, Yang RC, Chang HC, Hsu CH, Fang JT. Korean red ginseng improves blood pressure stability in patients with intradialytic hypotension. Evid Based Complement Alternat Med. 2012; 2012:595271. Epub 2012 May 8 (SCI; IF=4.774; INTEGRATIVE & COMPLEMENTARY MEDICINE 1/22)

2)      Chang MY, Ong AC. Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin Pract. 2012; 120(1):c25-34; discussion c35. Epub 2011 Dec 23 (SCI; IF=2.038; UROLOGY & NEPHROLOGY 33/73)

3)      Chang MY, Ong AC*. Endothelin in Polycystic Kidney Disease. Contrib Nephrol. 2011; 172:200–09 (SCI; IF=1.487; UROLOGY & NEPHROLOGY 46/73)

4)      Chang MY, Lu JK, Tian YC, Chen YC, Hung CC, Huang YH, Chen YH, Wu MS, Yang CW, Cheng YC*. Inhibition of the P2X7 Receptor Reduces Cystogenesis in PKD. J Am Soc Nephrol. 2011; 22(9):1696-706. (SCI; IF= 9.663; UROLOGY & NEPHROLOGY 1/73)

5)      Chang MY*, Kuok CM, Chen YC, Ryu SJ, Tian YC, Wu-Chou YH, Tseng FJ, Yang CW. Comparison of Intracerebral Hemorrhage and Subarachnoid Hemorrhage in Patients with Autosomal-Dominant Polycystic Kidney Disease. Nephron Clin Pract. 2010;114(2):c158-c164. (SCI; IF=2.038; UROLOGY & NEPHROLOGY 33/73) (Corresponding Author)

6)      Chang MY*, Chen YM, Chen YC, Tian YC, Fang JT, Yang CW.  Concurrent Renal Cell Carcinoma and Central Nervous System Lymphoma in a Patient with Autosomal Dominant Polycystic Kidney Disease. Med Princ Pract. 2009; 18(6):486-9.  (SCI; IF=0.887; MEDICINE, GENERAL & INTERNAL 89/153) (Corresponding Author)

7)      Weng CJ, Chang MY*, Chen YC, Tian YC, Fang JT, Yang CW. Long-Term Online Hemodiafiltration Does Not Reduce the Frequency and Severity of Acquired Cystic Kidney Disease in Hemodialysis Patients. Ren Fail. 2009; 31(7):555-61. (SCI; IF=0.824; UROLOGY & NEPHROLOGY 61/73) (Corresponding Author)

8)      Chang MY, Ong AC*. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron Physiol. 2008; 108(1): 1-7. (SCI; IF=2.548; UROLOGY & NEPHROLOGY 22/73)

9)      Chang MY, Parker E, Nahas ME, Haylor JL, Ong AC*. Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2007; 18(2):560-9. (SCI; IF= 9.663; UROLOGY & NEPHROLOGY 1/73)

10)  Chang MY, Parker E, Ibrahim S, Shortland JR, Nahas ME, Haylor JL, Ong AC*. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol Dial Transplant. 2006; 21(8):2078-84. (SCI; IF=3.396; UROLOGY & NEPHROLOGY 15/73)